The AI Revolution in Drug Discovery: Unlocking the Future of Medicine

The journey to develop a single drug to treat a disease has long been an arduous and costly endeavor. Over the years, it has taken decades and cost billions of dollars to bring a new therapeutic to market. However, the drug discovery landscape is rapidly changing, thanks to the power of Artificial Intelligence (AI). In a recent interview with Esteemed journalist Emma Keeling in conversation with Alex Zhavoronkov, the founder and CEO of Insilico Medicine, we explore how AI is revolutionizing the drug discovery process, making it faster, more efficient, and more cost-effective.